REZULIN Drug Patent Profile
✉ Email this page to a colleague
When do Rezulin patents expire, and when can generic versions of Rezulin launch?
Rezulin is a drug marketed by Pfizer Pharms and is included in one NDA.
The generic ingredient in REZULIN is troglitazone. Additional details are available on the troglitazone profile page.
Summary for REZULIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 91 |
Clinical Trials: | 2 |
Patent Applications: | 3,992 |
Formulation / Manufacturing: | see details |
DailyMed Link: | REZULIN at DailyMed |
Recent Clinical Trials for REZULIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Novartis | Phase 2 |
National Cancer Institute (NCI) | Phase 2 |
Dana-Farber Cancer Institute | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for REZULIN
US Patents and Regulatory Information for REZULIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-001 | Jan 29, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-003 | Aug 4, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-002 | Jan 29, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for REZULIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-001 | Jan 29, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-001 | Jan 29, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-002 | Jan 29, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-001 | Jan 29, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer Pharms | REZULIN | troglitazone | TABLET;ORAL | 020720-002 | Jan 29, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for REZULIN
See the table below for patents covering REZULIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 3674089 | ⤷ Try a Trial | |
Denmark | 87886 | ⤷ Try a Trial | |
Canada | 1263395 | COMPOSES A BASE DE [5-(4-CHROMAN-2-YLALCOXY) BENZYL]-THIAZOLIDINE ([5-(4-CHROMAN-2-YLALKOXY)BENZYL]-THIAZOLIDINE COMPOUNDS) | ⤷ Try a Trial |
Canada | 2272478 | ⤷ Try a Trial | |
Denmark | 0719143 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for REZULIN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0139421 | SPC/GB97/084 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: TROGLITAZONE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK 10949/0277 19970729; UK 10949/0278 19970729; UK 10949/0279 19970729; UK 06384/0005 19970729; UK 06384/0006 19970729; UK 06384/0007 19970729 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |